D-1461-2016 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-1461-2016 was initiated by Zydus Pharmaceuticals USA Inc on Jul 19, 2016 and is designated Class II. Reason for recall: Failed Dissolution Specifications: out of specification dissolution results in retained samples The recall status is terminated (terminated Sep 21, 2020).

Recall details

Product Type
Drugs
Report Date
Aug 24, 2016
Initiation Date
Jul 19, 2016
Termination Date
Sep 21, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.

Reason for recall

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Distribution pattern

Nationwide

Code information

Lot #: a) MS1217, MS1218 , Exp.12/2017. Lot #: b) MS1215, Exp.12/2017 Lot #: c) MR11150, MR11151, MR11854, Exp. 10/2017; MR11798, MR11799, MS1214, Exp.11/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1461-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1461-2016. Report a data issue: hello@regdatalab.com.